Dr. Padmini Bhadriraju, MD

Dr. Bhadriraju practices at Knapp Medical Group in Weslaco, Texas.

Dr. Bhadriraju's NPI, 1518991447, was assigned on July 10, 2006. Dr. Bhadriraju graduated from Andhra Medical College NTR in 1990. Dr. Bhadriraju holds Texas license N3498.

Dr. Bhadriraju's primary practice is Knapp Medical Group, at 1315 E 6th St Ste 6, Weslaco, TX 78596. The practice phone is (956) 565-2727.

Dr. Bhadriraju's primary practice is Knapp Medical Group in Weslaco, Texas. Dr. Bhadriraju is also affiliated with Knapp Medical Center. The medical group on file is HNI Healthcare. Dmand AI also links Dr. Bhadriraju to 4 more hospitals, 5 group practices and clinics, 5 medical groups and 1 skilled nursing facility, each named with a free account. Dr. Bhadriraju's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhadriraju practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bhadriraju's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bhadriraju is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bhadriraju's licenses on file in 3 states: Texas, North Carolina and Michigan.

Dmand AI lists acid reflux, acute diabetes, acute gastroduodenitis, acute respiratory failure, acute sinusitis, anemia, aneurysm and anxiety among the conditions Dr. Bhadriraju treats.

CMS data shows 4,670 Medicare services from Dr. Bhadriraju across 17 procedure codes in 2024, for 777 Medicare patients. Medicare paid $403,689 for them.

CMS counts 777 Medicare patients who saw Dr. Bhadriraju in 2024. The largest group is 75 to 84, with 250 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhadriraju's median patient age at 59, with 58% women.

In 2024, Dr. Bhadriraju wrote 2,602 Medicare Part D claims for 300 patients. 86% of them were for generic drugs. CMS names the drug for 1,972 of them, across 60 drugs with 11 or more claims each, at $194,545 in total drug cost. In 2023, CMS named 2,557 claims across 74 drugs.

Dr. Bhadriraju accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhadriraju as offering telehealth.

Dmand AI links 1 paper to Dr. Bhadriraju in 2006. Dr. Bhadriraju's most frequent co-author is Satish Bhadriraju, MD.

CMS Open Payments shows 40 general payments to Dr. Bhadriraju from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $135.

Dmand AI lists 1 award for Dr. Bhadriraju, most recently CMS Stage 1 EHR in 2013.

Dr. Bhadriraju graduated from Andhra Medical College NTR in 1990.

Dr. Bhadriraju is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.